Faromco SRL
Faromco reported total assets of 36,931 € at the end of the 2025 financial year (annual accounts filed with the NBB on 11 May 2026).
The score of Faromco shows with a free account.
See the score- Summary? / 5
- Balance sheet strength
- Liquidity
- Repayment capacity
- Profitability
- Trajectory
- Compliance and register
- Position in its sectorvs peers
- Supplier creditat 30 d
- Borrowing capacityborrowable
- Valuationcentral
Visible once signed in: create your account, the 14-day Pro trial is free.
Key figures 2025
Change 2022 → 2025: Equity -34 % Total assets -32 %
Accounts of the company itself (not consolidated).
The full file covers 10 financial years; a free account shows 2. →Deterministic calculation on the filed accounts, no AI. Dispute the score or report an error
Faromco's annual accounts
Filed annual accounts
- Year ended 31 Dec 2025filed on 11 May 2026
- Year ended 31 Dec 2024filed on 19 Jun 2025
- Year ended 31 Dec 2023filed on 09 Jul 2024
- Year ended 31 Dec 2022filed on 30 Jun 2023
- Year ended 31 Dec 2021filed on 02 Jun 2022
Faromco's financial analysis
- Solvency80.8%sector median: 44.2%
- Current ratio
- Net margin
- ROE
- Financial debt / EBITDA
- Interest coverage
- Days sales outstanding (DSO)
Management and control of Faromco
Faromco's publications in the Belgian Gazette
Company number, VAT number and registered office
- Company number (CBE)
- 0540.560.016
- VAT number
- BE0540560016
- Peppol
- Registered · 0208:0540560016 · as of 10 Nov 2026
- Legal form
- SRL
- Incorporated
- 01 Oct 2013
- Registered office
- 2620 Hemiksem
- Latest accounts
- 2025 · filed on 11 May 2026
- Activity
- Retail sale of pharmaceutical products (NACE 47730)
Faromco (SRL) has been based in Hemiksem since 2013, active in: retail sale of pharmaceutical products. For 2025, it reports a net profit of 150 € and equity of 29,827 €; its revenue is not published. Its solvency stands at 80.8%, above the median of its sector (44.2%).
Guide: Reading Belgian SME accounts: the five figures that count →
Companies similar to Faromco
Companies in the same business, of comparable size and area, outside its group.
- Sophie Delabie Manufacture of pharmaceutical preparations Willebroek · balance sheet 183,627 €
- Hubert Services Management Retail sale of pharmaceutical products Estinnes · balance sheet 65,144 €
- Pharmacycle Retail sale of pharmaceutical products Brussels · balance sheet 41,191 €
- Quantum Satis Retail sale of pharmaceutical products Zele · balance sheet 34,289 €
- InEssence Studio Retail sale of pharmaceutical products Auderghem · balance sheet 29,309 €
- Kephas Pharma Retail sale of pharmaceutical products Pont-à-Celles · balance sheet 57,577 €
- Mieke de Geeter Retail sale of pharmaceutical products Kortrijk · balance sheet 58,191 €
- Farma & Fit Retail sale of pharmaceutical products Rotselaar · balance sheet 71,427 €
Frequently asked questions about Faromco
What is the revenue of Faromco?
Faromco files its accounts in a format where revenue is optional: it is not published for 2025.
What is the VAT number of Faromco?
In Belgium, the VAT number is the company number prefixed with BE: BE0540560016 for Faromco, if the company is VAT-registered. Its company number (CBE) is 0540.560.016.
Where is the registered office of Faromco?
According to the CBE register, the registered office of Faromco is in 2620 Hemiksem.
What is the equity of Faromco?
At the close of the 2025 financial year, the equity of Faromco amounts to 29,827 €, a solvency of 80.8% of total assets.
Who manages Faromco?
The register lists 1 active mandates at Faromco. Names and roles are in the full file, with the deeds published in the Belgian Gazette.
The full file of Faromco
Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.
Open the full file →